Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression
- 1 November 1992
- journal article
- Published by Springer Nature in Nature
- Vol. 360 (6401) , 266-268
- https://doi.org/10.1038/360266a0
Abstract
Class II major histocompatibility complex (MHC) molecules function as antigen-presenting elements as well as signal transducers on B lymphocytes. We previously reported that a B lymphoma cell transfectant, 5C2, expressing genetically engineered I-Ak molecules with truncated cytoplasmic domains was severely impaired in both antigen presentation and in anti-Ia-induced intracytoplasmic signalling. These two functions could be restored by preculturing 5C2 cells with cyclic AMP analogues. Here we demonstrate that impaired signal transduction by truncated class II molecules results in a deficiency in induction of the newly defined B-cell accessory molecule B7 (ref. 8), which can be reversed by restoration of B7 expression. These data imply that contact of the T-cell antigen receptor with MHC/antigen ligand results in signal transmission through the class II cytoplasmic domain. This signal, which can be mimicked by dibutyryl cAMP, induces expression of B7, resulting in effective antigen presentation. The fact that crosslinking of surface class II MHC also induces B7 expression on normal resting human B cells supports this contention.Keywords
This publication has 20 references indexed in Scilit:
- Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathwayCellular Immunology, 1991
- Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.The Journal of Experimental Medicine, 1991
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991
- Direct helper T cell‐induced B cell differentiation involves interaction between T cell antigen CD28 and B cell activation antigen B7European Journal of Immunology, 1991
- The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.The Journal of Experimental Medicine, 1991
- Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.The Journal of Experimental Medicine, 1991
- Role of the CD28 receptor in T-cell activationImmunology Today, 1990
- Altered I-A protein-mediated transmembrane signaling in B cells that express truncated I-Ak protein.Proceedings of the National Academy of Sciences, 1989
- Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytesNature, 1987
- The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product.The Journal of Experimental Medicine, 1983